Clearstead Advisors LLC Has $478,000 Stock Holdings in Centene Corporation $CNC

Clearstead Advisors LLC boosted its stake in shares of Centene Corporation (NYSE:CNC) by 682.9% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 13,387 shares of the company’s stock after buying an additional 11,677 shares during the period. Clearstead Advisors LLC’s holdings in Centene were worth $478,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in CNC. UniSuper Management Pty Ltd lifted its holdings in shares of Centene by 66.0% in the third quarter. UniSuper Management Pty Ltd now owns 85,232 shares of the company’s stock valued at $3,041,000 after purchasing an additional 33,875 shares in the last quarter. Packer & Co Ltd acquired a new stake in Centene in the 3rd quarter valued at approximately $50,487,000. ARGA Investment Management LP acquired a new position in Centene during the 3rd quarter worth approximately $21,485,000. First Citizens Bank & Trust Co. grew its stake in shares of Centene by 122.5% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 223,157 shares of the company’s stock worth $7,962,000 after acquiring an additional 122,870 shares in the last quarter. Finally, Amundi raised its holdings in shares of Centene by 6.2% in the second quarter. Amundi now owns 3,384,752 shares of the company’s stock valued at $183,724,000 after purchasing an additional 199,016 shares during the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Centene Price Performance

Shares of NYSE CNC opened at $42.99 on Friday. Centene Corporation has a twelve month low of $25.08 and a twelve month high of $66.03. The company has a market cap of $21.14 billion, a PE ratio of -3.16, a price-to-earnings-growth ratio of 0.95 and a beta of 0.48. The business’s 50 day moving average price is $42.72 and its two-hundred day moving average price is $37.35. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.87.

Centene (NYSE:CNC) last posted its earnings results on Friday, February 6th. The company reported ($1.19) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.22) by $0.03. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The business had revenue of $49.73 billion for the quarter, compared to analyst estimates of $48.41 billion. During the same period in the previous year, the firm earned $0.80 EPS. The firm’s revenue was up 21.9% compared to the same quarter last year. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. On average, analysts predict that Centene Corporation will post 6.86 EPS for the current year.

Analyst Upgrades and Downgrades

CNC has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft raised their target price on shares of Centene from $32.00 to $39.00 and gave the company a “hold” rating in a research report on Tuesday, February 10th. Argus upgraded shares of Centene to a “hold” rating in a research note on Monday, February 9th. Jefferies Financial Group lowered their target price on Centene from $43.00 to $37.00 and set a “hold” rating on the stock in a research report on Friday, February 13th. Wall Street Zen cut Centene from a “buy” rating to a “hold” rating in a research report on Sunday, February 15th. Finally, Sanford C. Bernstein restated an “outperform” rating and issued a $59.00 price target on shares of Centene in a research note on Tuesday, January 6th. Three research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $42.00.

Centene Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.